Medicamen Biotech Limited (MEDICAMEQ) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Medicamen Biotech Limited (MEDICAMEQ) has a cash flow conversion efficiency ratio of -0.045x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-124.06 Million ≈ $-1.34 Million USD) by net assets (Rs2.75 Billion ≈ $29.78 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see MEDICAMEQ stock market capitalisation for the company's overall valuation and market capitalisation.
Medicamen Biotech Limited - Cash Flow Conversion Efficiency Trend (2006–2026)
This chart illustrates how Medicamen Biotech Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Medicamen Biotech Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medicamen Biotech Limited ranked by their cash flow conversion efficiency. Explore Medicamen Biotech Limited (MEDICAMEQ) cash earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
HLV LIMITED
NSE:HLVLTD
|
0.007x |
|
Wästbygg Gruppen AB (publ)
ST:WBGR-B
|
-0.225x |
|
Elinoil Hellenic Petroleum Company S.A
AT:ELIN
|
0.505x |
|
Agile Content SA
MC:AGIL
|
-0.035x |
|
Lesico Ltd
TA:LSCO
|
0.226x |
|
Ckd Bio
KO:063160
|
0.022x |
|
Promateris SA
RO:PPL
|
N/A |
|
W S Industries (I) Limited
NSE:WSI
|
0.030x |
Annual Cash Flow Conversion Efficiency for Medicamen Biotech Limited (2006–2026)
The table below shows the annual cash flow conversion efficiency of Medicamen Biotech Limited from 2006 to 2026. View Medicamen Biotech Limited stock quote for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs2.76 Billion ≈ $29.80 Million |
Rs-349.31 Million ≈ $-3.78 Million |
-0.127x | -173.60% |
| 2025-03-31 | Rs2.13 Billion ≈ $23.01 Million |
Rs-98.59 Million ≈ $-1.07 Million |
-0.046x | -42.21% |
| 2024-03-31 | Rs2.07 Billion ≈ $22.38 Million |
Rs-67.44 Million ≈ $-729.32K |
-0.033x | -0.14% |
| 2023-03-31 | Rs1.93 Billion ≈ $20.92 Million |
Rs-62.93 Million ≈ $-680.54K |
-0.033x | -215.97% |
| 2022-03-31 | Rs1.46 Billion ≈ $15.84 Million |
Rs41.09 Million ≈ $444.38K |
0.028x | -70.81% |
| 2021-03-31 | Rs1.33 Billion ≈ $14.37 Million |
Rs127.72 Million ≈ $1.38 Million |
0.096x | -9.00% |
| 2020-03-31 | Rs1.21 Billion ≈ $13.11 Million |
Rs128.02 Million ≈ $1.38 Million |
0.106x | +112.74% |
| 2019-03-31 | Rs866.34 Million ≈ $9.37 Million |
Rs43.01 Million ≈ $465.12K |
0.050x | +167.91% |
| 2018-03-31 | Rs746.08 Million ≈ $8.07 Million |
Rs-54.54 Million ≈ $-589.80K |
-0.073x | -154.50% |
| 2017-03-31 | Rs267.81 Million ≈ $2.90 Million |
Rs35.92 Million ≈ $388.49K |
0.134x | -61.29% |
| 2016-03-31 | Rs179.09 Million ≈ $1.94 Million |
Rs62.06 Million ≈ $671.13K |
0.347x | +281.86% |
| 2015-03-31 | Rs171.85 Million ≈ $1.86 Million |
Rs-32.74 Million ≈ $-354.11K |
-0.191x | -161.32% |
| 2014-03-31 | Rs165.38 Million ≈ $1.79 Million |
Rs51.39 Million ≈ $555.74K |
0.311x | +410.42% |
| 2013-03-31 | Rs157.17 Million ≈ $1.70 Million |
Rs-15.73 Million ≈ $-170.14K |
-0.100x | +42.34% |
| 2012-03-31 | Rs201.01 Million ≈ $2.17 Million |
Rs-34.90 Million ≈ $-377.38K |
-0.174x | -131.21% |
| 2011-03-31 | Rs204.12 Million ≈ $2.21 Million |
Rs113.52 Million ≈ $1.23 Million |
0.556x | +722.44% |
| 2010-03-31 | Rs162.61 Million ≈ $1.76 Million |
Rs11.00 Million ≈ $118.92K |
0.068x | -89.45% |
| 2009-03-31 | Rs129.60 Million ≈ $1.40 Million |
Rs83.07 Million ≈ $898.33K |
0.641x | +227.09% |
| 2008-03-31 | Rs115.83 Million ≈ $1.25 Million |
Rs22.70 Million ≈ $245.46K |
0.196x | +662.67% |
| 2007-03-31 | Rs100.73 Million ≈ $1.09 Million |
Rs2.59 Million ≈ $27.99K |
0.026x | -91.54% |
| 2006-03-31 | Rs85.67 Million ≈ $926.49K |
Rs26.02 Million ≈ $281.45K |
0.304x | -- |
About Medicamen Biotech Limited
Medicamen Biotech Limited, a pharmaceutical company, research, develops, manufactures, markets, sells, and distributes pharmaceutical formulations in India and internationally. The company offers drugs in various forms, including tablet, capsule, syrups, oral solution, and drops. Its products are used in therapeutic areas comprising cancer care, cardiology, CNS, diabetology, anti-infective, anti-… Read more